|
|
|
|
| First Name: | Eva | | Last Name: | Hedlund | | Title: | PhD, Associate professor of Neurobiology | | Affiliation: | Karolinska Institutet | | Department: | Department of Neuroscience | | Street Address 1: | Retzius v. 8 | | Street Address 2: | 171 77 | | City: | Stockholm | Country/Territory: | Sweden | | Phone: | +46852487851 | | Fax: | +468320988 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports no financial or other potential conflicts of interest. [Last Modified: 9 January 2012]
|
|
|
View all comments by Eva Hedlund
|
Parkinson Disease, Aging Process, Neuromuscular Disorders (ALS, etc.)
|
Animal Models, Neurobiology, Neuropathology, Microscopy, Molecular and Cell biology, Bioinformatics/Statistics, DNA microarrays, Signal transduction, Stem cells
|
Research institute, University
|
Is an associate professor of Neurobiology at the Karolinska Institutet in Stockholm, Sweden. Her main research focus is on motor neuron vulnerability in motor neuron disorders such as ALS, SMA and SBMA. Dr Hedlund received her PhD from the Karolinska Institute, Sweden in 2000. Thereafter she conducted postdoctoral research regarding spinal cord development and spinal cord injury at the University of California Los Angeles, USA. In 2002 (until 2007) she joined the Center for Neuroregeneration Research at Harvard Medical School, MA, USA to work on stem cell therapies for ALS and Parkinson’s disease, intially as a postdoctoral fellow and later on as junior faculty. She continued her work on directing stem cells into appropriate neuronal cell fates, with the aim of developing cellular replacement therapies and understanding mechanisms of neuronal development as a research associate at the Ludwig Institute for Cancer Research, in Stcokholm, Sweden. She is now heading her own reseearch group at the Department of Neuroscience, Karolinska Institutet. She is a member of the scientific advisory board of the Thierry Latran Foundation (dedicated to ALS and protection of motor neuron research) and is an editorial board member of the Open Journal of Neuroscience. She serves as an ad hoc grant reviewer to several foundations regarding stem cells and neurodegenerative disorders and to more than 15 different scientific journals. Her current work focuses on stem cell approaches to understand motor neuron development and disease, as well as molecular analyses to investigate the processes that make certain populations of motor neurons more resistant and others more vulnerable to degeneration in ALS.
|
|
|
|
|
|
|